Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Macrogen Inc.

Headquarters: Seoul, South Korea
Year Founded: 1997
Status: Public
Industry Sector: HealthServices
CEO: Su-Gang Lee
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -19.62
Exchange/Ticker 1: KOSDAQ:038290
Exchange/Ticker 2: N/A
Latest Market Cap: $107,797,967

BioCentury | Nov 18, 2022
Regulation

Nov. 17 Quick Takes: FDA approves Provention’s mAb to slow onset of diabetes

Plus: Rezo’s launch, deals by Regeneron-CytomX and Marinus-Tenacia, the end of a GSK-Immatics deal, and Tenaya’s funding
BioCentury | Oct 18, 2022
Deals

Oct. 17 Quick Takes: Gilead, MacroGenics in deal for bispecific

Biogen’s ALS candidate delayed, plus updates from Oculis, Treeline, Minerva, Acrivon and more
BioCentury | Dec 7, 2018
Tools & Techniques

Germline editing gets technical

Why there’s a gap in standards research for somatic cell versus germline editing
BioCentury | Apr 28, 2016
Finance

Public-Private Partnership Roundup

Highlights of public-private partnerships from 1Q16
BioCentury | Jan 20, 2014
Company News

Illumina sales and marketing update

BioCentury | Jan 15, 2014
Company News

Illumina introduces $1,000 human genome system

BioCentury | Mar 1, 2012
Cover Story

REThinking lung cancer

BioCentury | Aug 2, 2010
Company News

Illumina sales and marketing update

BioCentury | Jul 9, 2001
Company News

Macrogen Inc. other research news

Items per page:
1 - 10 of 10